Correlation Between Biophytis and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Biophytis and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biophytis and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biophytis and SAB Biotherapeutics, you can compare the effects of market volatilities on Biophytis and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biophytis with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biophytis and SAB Biotherapeutics.
Diversification Opportunities for Biophytis and SAB Biotherapeutics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Biophytis and SAB is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Biophytis and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Biophytis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biophytis are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Biophytis i.e., Biophytis and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Biophytis and SAB Biotherapeutics
If you would invest 300.00 in SAB Biotherapeutics on September 21, 2024 and sell it today you would earn a total of 90.00 from holding SAB Biotherapeutics or generate 30.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Biophytis vs. SAB Biotherapeutics
Performance |
Timeline |
Biophytis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
SAB Biotherapeutics |
Biophytis and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biophytis and SAB Biotherapeutics
The main advantage of trading using opposite Biophytis and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biophytis position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.Biophytis vs. NRx Pharmaceuticals | Biophytis vs. NRX Pharmaceuticals | Biophytis vs. Akari Therapeutics PLC | Biophytis vs. Armata Pharmaceuticals |
SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |